Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial

BACKGROUND: A cyclic corticosteroid-cyclophosphamide regimen is the first-line therapy for membranous nephropathy. Compared with this regimen, rituximab therapy might have a more favorable safety profile, but a head-to-head comparison is lacking. METHODS: We randomly assigned 74 adults with membrano...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Soc Nephrol
Main Authors: Scolari, Francesco, Delbarba, Elisa, Santoro, Domenico, Gesualdo, Loreto, Pani, Antonello, Dallera, Nadia, Mani, Laila-Yasmin, Santostefano, Marisa, Feriozzi, Sandro, Quaglia, Marco, Boscutti, Giuliano, Ferrantelli, Angelo, Marcantoni, Carmelita, Passerini, Patrizia, Magistroni, Riccardo, Alberici, Federico, Ghiggeri, Gian Marco, Ponticelli, Claudio, Ravani, Pietro
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Nephrology 2021
Assuntos:
Clinical Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8017548/
https://ncbi.nlm.nih.gov/pubmed/33649098
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2020071091
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados